HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
WRBY
Warby Parker Inc.
WRBY's fundamentals are strong: earnings per share more than tripled and revenue grew 9.9%, though free cash flow fell 44%. At 535x earnings, it's trading less than half its usual 2277x. Analysts expect that strong growth to continue, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
WRBY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
WRBY's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
WRBY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 53x | $26.73 | — |
| Cheap | 439x | $21.93 | -18% |
| Current | 535x | $26.73 | — |
| Fair | 2,274x | $114 | +325% |
| Expensive | 2,646x | $132 | +395% |
Historical ranges are pointers, not guarantees.
WRBY's PE is in its cheap range at 535x. If earnings grow as analysts expect, today's price would be 53x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
WRBY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
WRBY has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
WRBY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.51 | +916% |
| Q3 2026 | $0.05 | +400% |
| Q2 2026 | $0.06 | +$0.13 |
| Q1 2026 | $0.01 | +$0.13 |
| Q4 2025 | $0.01 | +$0.18 |
| Q3 2025 | $0.01 | +$0.28 |
| Q2 2025 | -$0.07 | +$0.32 |
| Q1 2025 | -$0.12 | +$0.35 |
| Q4 2024 | -$0.17 | +$0.37 |
WRBY has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over WRBY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
WRBY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $244.7M | +10% |
| Q2 2026 | $235.5M | +9.8% |
| Q1 2026 | $242.4M | +8.3% |
| Q4 2025 | $212M | +11% |
| Q3 2025 | $221.7M | +15% |
| Q2 2025 | $214.5M | +14% |
| Q1 2025 | $223.8M | +12% |
| Q4 2024 | $190.6M | +18% |
WRBY's revenue has grown year over year every quarter since early 2021: $245M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | -0.2 points |
| Q2 2026 | 1.3% | +3.5 points |
| Q1 2026 | 0.7% | -0.4 points |
| Q4 2025 | -3.2% | +1.7 points |
| Q3 2025 | 1.6% | +5 points |
| Q2 2025 | -2.1% | +2.6 points |
| Q1 2025 | 1.1% | +3.7 points |
| Q4 2024 | -4.9% | +8.4 points |
WRBY has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over WRBY on cash flow, with more consistent year-over-year improvement.
WRBY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2M | -$459K |
| Q2 2026 | $6.8M | -72% |
| Q1 2026 | $8.4M | -37% |
| Q4 2025 | $8.1M | +271% |
| Q3 2025 | -$1.5M | -112% |
| Q2 2025 | $23.9M | +71% |
| Q1 2025 | $13.2M | +141% |
| Q4 2024 | $2.2M | +2282% |
WRBY usually generates cash, though not every quarter: the latest was −$2M, but it generated $21M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over WRBY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
WRBY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +401K shares |
| 1 year | +0.6% | +741K shares |
| 3 years | +6.9% | +8.1M shares |
| 5 years | +101% | +63.3M shares |
WRBY has 126M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q2 2021 | $2M |
| Q1 2021 | $6.1M |
| Q4 2020 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
WRBY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.1x | Net Cash |
| Q2 2026 | -5.3x | Net Cash |
| Q1 2026 | -6.3x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -6.7x | Net Cash |
| Q2 2025 | -9.3x | Net Cash |
| Q1 2025 | -10.6x | Net Cash |
| Q4 2024 | -16.1x | Net Cash |
WRBY has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
WRBY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 40.8 | Neutral |
WRBY's weekly RSI is 53 (neutral) and its Stochastic is 41 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
WRBY PE vs Healthcare Sector
| Metric | WRBY | Sector median | Relative |
|---|---|---|---|
| PE | 535x | 26x | 1,968% above |
| PE % | 26 | 39 | 13 pts below |
WRBY is trading at 535x earnings, a 1968% premium to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
WRBY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.6 | 4.3% above |
| 20 week MA | $25.9 | 3.3% above |
| 50 week MA | $25.2 | 6.2% above |
| 100 week MA | $23.7 | 13% above |
| 200 week MA | $18.9 | 42% above |
WRBY has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
WRBY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $53.7 | $47.5 | -12% |
| 2022 | $47.5 | $13.5 | -72% |
| 2023 | $13.5 | $14.1 | +4.2% |
| 2024 | $14.1 | $24.4 | +73% |
| 2025 | $24.4 | $24.2 | -1% |
| 2026 YTD | $24.2 | $26.7 | +11% |
WRBY has the edge over HIMS on returns for 2026, with the stronger performance.